24 trends tracked about this subject — the full history, oldest to newest below.
Moderna and Merck trial data sparks debate over whether a personalized medicine revolution is beginning.
Health coverage highlights FDA approval of Moderna's new mRNA flu vaccine and emerging studies on broader antibody responses.
Personalized mRNA cancer vaccines are gaining momentum following Phase III success in melanoma and expanded global clinical trials.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
GSK is advancing a new mRNA flu vaccine to Phase III trials after the candidate outperformed standard vaccinations in earlier testing.
BioNTech and Genentech have terminated a phase 2 mRNA colorectal cancer vaccine trial after safety reviews revealed more deaths than in the control group.
The FDA has approved Moderna's mRNA-based flu vaccine, marking a shift in immunization technology for older adults.
Advancements in mRNA technology are driving the development of cancer vaccines, specifically targeting melanoma and expanding medical breakthroughs.
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Moderna and Merck's mRNA melanoma vaccine is drawing significant attention as a potential game changer according to recent coverage.
Moderna and Merck report success in a late-stage melanoma trial for their personalized mRNA cancer vaccine.
An mRNA flu shot becomes available in the United States for the first time, according to Smithsonian Magazine.
The first mRNA-based flu vaccine has been approved in the US, specifically targeting adults aged 50 and over for improved effectiveness.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The U.S. has approved the first-ever mRNA flu vaccine from Moderna, though concerns over side effects may impact public adoption.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Personalized gene therapy using bespoke ASOs has enabled a teen with SCN2A-related epileptic encephalopathy to walk independently for the first time.
Advancements in mRNA technology have brought the development of an HIV vaccine closer to reality through new neutralizing antibody responses.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
An FDA advisory committee has unanimously recommended the approval of Moderna's mRNA influenza vaccine for older adults.
An FDA advisory committee has unanimously backed Moderna's mRNA-based flu vaccine, marking a significant development for the technology.
Moderna stock prices increased following positive feedback from the FDA regarding the company's mRNA influenza vaccine candidate.